Mira Pharmaceuticals (MIRA) Enterprise Value (2022 - 2025)

Mira Pharmaceuticals has disclosed Enterprise Value across 4 years of filings, most recently posting -$11.0 million for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$11.0 million, down 289.35% year-over-year; the trailing twelve-month figure through Dec 2025 was -$11.0 million (down 289.35% YoY), and the FY2025 annual result was -$11.0 million, down 289.35% from the prior year.
• Enterprise Value came in at -$11.0 million for Q4 2025 at Mira Pharmaceuticals, down from -$7.5 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$1349.0 in Q1 2023 to a low of -$11.0 million in Q4 2025.
• The 4-year median for Enterprise Value is -$2.0 million (2024), against an average of -$3.1 million.
• Across the five-year window, Enterprise Value soared 96.99% in 2023 and slumped 259351.45% in 2024, its largest moves.
• Mira Pharmaceuticals' Enterprise Value stood at -$350978.0 in 2022, then plunged by 1211.35% to -$4.6 million in 2023, then soared by 38.45% to -$2.8 million in 2024, then sank by 289.35% to -$11.0 million in 2025.
• The last three Enterprise Value figures came in at -$11.0 million (Q4 2025), -$7.5 million (Q3 2025), and -$730475.0 (Q2 2025), per Business Quant data.